According to the research report titled ‘GLOBAL Peripheral Vascular Devices Market 2021-2028’, available with Market Study Report, global peripheral vascular devices market is anticipated to register 11.54% CAGR over the forecast duration 2021-2028.
 

Prevalence of peripheral arterial disease leading to the demand of minimally invasive procedures for treatment is a major growth catalyst for worldwide peripheral vascular devices industry. Also, factors like increasing geriatric populace and changing lifestyle, along with rapid technological advancements are propelling the market outlook.

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552227/

On the contrary, dearth of proper reimbursement policies for peripheral vascular devices, alongside strict regulatory scenario are likely to restrain the growth of the industry.

In terms of device type, global peripheral vascular devices market is classified into peripheral vascular stents (self-expanding, balloon expanding, drug-eluting, covered stents), percutaneous transluminal angioplasty balloon catheters (standard, large, high-pressure, small, drug-coated, specialty), and percutaneous transluminal angioplasty guidewires (including embolic protection devices, atherectomy devices, inferior vena cava filters, others).
 

Moving on to regional landscape, the study includes the current industry trends across North America, Middle East & Africa, Asia Pacific, Europe, and Latin America.
 

As per estimates, Asia Pacific peripheral vascular devices industry share is expected to bolster at a significant growth rate in the stipulated period, owing to increasing discretionary income, surging healthcare expenses, and adoption of advanced vascular devices for the elderly populace, generating prospects for key players.
 

The competitive landscape of worldwide peripheral vascular devices marketplace is defined by companies such as Becton Dickinson and Company (BD), Terumo Interventional Systems Inc., Cordis Corp., Edwards Lifesciences, Boston Scientific Corporation, Medtronic plc, Spectranetics Corporation, Koninklijke Philips N.V., Abbott Laboratories, Endologix LLC, Teleflex Incorporated, and Cook Group Incorporated among others.